9th International
Lung Cancer Network

23-25 June 2023 Athens Marriott Hotel, Athens Greece

View Schedule Online Registration

Welcome

Dear Colleagues and Friends,

We are excited to invite you to join us at the 9th International Lung Cancer Network (ILCN) taking place on site at Athens, Greece from Friday 23rd to Sunday 25th June 2023.
This bi-annual international lung cancer meeting continues its tradition of multidisciplinary networking, by bringing together some of the top lung cancer experts, from across the globe. Debates, State-of-the Art lectures, multidisciplinary sessions, and extended panel discussions will encourage interaction with the faculty members and will address ongoing clinical challenges and controversies, in current lung cancer management. Participants will have the opportunity to understand the reasoning behind clinical trials, the interpretation of the results and the application in the clinical practice, for the optimal patient care. International lung cancer experts from the basic and clinical research, the academia and the industry will share their personal experiences and will present early clinical data, ongoing clinical trials, innovative technologies, and strategies, in the effort to provide state–of–the art care today and shape the future of lung cancer management.
We invite you to save the date for the 9th International Lung Cancer Network (ILCN) in Athens, Greece (23rd – 25th June 2023).
We hope you will join us on site for this very informative and timely meeting.

The chairs

Kostas Syrigos

Kostas Syrigos, MD, PhD, FCCP
Athens School of Medicine, GR

Roy S. Herbst

Roy S. Herbst, MD, PhD
Ensign Professor of Medicine
Deputy Director
Yale Cancer Center and Smilow Cancer Hospital
Assistant Dean for Translational Research
Yale School of Medicine

Fred Hirsch

Fred Hirsch, MD, PhD
Icahn Medical School, Mount Sinai, NY

About The
Conference

The 9th International Lung Cancer Network (ILCN) will review the latest data on immunotherapy, targeted therapies, surgery, and radiation oncology, will present ongoing clinical trials, diagnostic technologies, and predictive strategies, in the effort to provide state–of–the art care today and shape the future of lung cancer management.

Athens Marriott Hotel, Syngrou Avenue 385, Athens, 17564 Greece

Learning Objectives

 

  • Explain the optimal use of biomarkers in all stages of lung cancer.
  • Discuss the emerging evidence of omics technologies and artificial intelligence in view of the application of precision medicine in thoracic malignancies.
  • Debate the results from recent clinical trials and how these change the clinical practice.
  • Apply patient characteristics, tumor markers, clinical trial evidence and combination treatment strategies to optimize the individualized approach
  • Summarize of resistance to treatment and optimal sequencing of therapeutic strategies.
  • Review the optimal therapeutic approaches in various subgroups of thoracic malignancies and in micrometastatic disease.

Target Audience

This appealing congress is addressed to medical, surgical, and radiation oncologists interested in the treatment of patients with lung cancer. Pathologists, Pulmonologists and basic scientists will also benefit from the multidisciplinary program. Fellows, nurses, family physician, pharmacists, researchers, and other health care professionals working in the area of thoracic malignancies are invited to participate.

 

Accreditation

CME/CE accreditation will be provided

 

Online Registration

Scientific Program

THE PERPETUAL QUEST OF NEW TARGETS

9:00 - 10:30

THE PERPETUAL QUEST OF NEW TARGETS
Chairs: George Lainakis, Vassilis Ramfidis, Lydia Abou - Asabeh

09:00-09:20 Transcending ALK resistance: Ilias Athanasiadis
09:20-09:40 Targeting HER2 in NSCLC: Anastasia Papafili
09:40-10:00 DLL3: an emerging target in SCLC: Fred Hirsch
10:00-10:20 Parp inhibitors combined with I-O: Marili Mani
10:20-10:30 Q&A

FROM THE BENCH TO BEDSIDE

10:30 - 11:30

FROM THE BENCH TO BEDSIDE
Chairs: Keith M. Kerr, Kalliopi Athanassiadi, Vasiliki Nikolaidou

10:30-10:50 Analyzing the tumor microenvironment in EGFR- positive disease: Jon Zugazagoitia
10:50-11:10 Targeting BRAF-mutant NSCLC: Maria Toki
11:10-11:30 Circulating Tumor DNA in the Treatment of Patients With LC: Natasha Leighl

Coffee Break – Delegates Networking

11:30 - 12:00
Coffee Break – Delegates Networking

ΙNVITED LECTURE

12:00 - 12:30

ΙNVITED LECTURE
Chairs: Fred Hirsch, Christos Christodoulou

12:00-12:30 Dissecting the NSCLC tumor microenvironment: the good, the bad and the ugly: Kurt A. Schalper

ΙNVITED LECTURE

12:30 - 13:00

ΙNVITED LECTURE
Chairs: Ioannis G. Kaklamanos, Epaminondas Samantas

12:30-13:00 Lineage Plasticity in lung cancer: the Devil is in the Details: Triparna Sen

LUNG CANCER SUSCEPTIBILITY

13:00 - 14:00

LUNG CANCER SUSCEPTIBILITY
Chairs: Stelios Loukides, Eleftherios Zervas, Florentia Fostira

13:00-13:20 The hereditary element of LC:Periklis Makrythanasis
13:20-13:40 Long-term exposure to air pollution: Dionisios Spyratos
13:40-14:00 LC beyond smoking: Sofia Lampaki

INDUSTRY PIPELINE (I)

14:00 - 14:30

INDUSTRY PIPELINE (Ι)
Chairs: Alexios Strimpakos, Dimitra Kanaloupiti

14:00-14:30 Transform the Lung Cancer Therapeutic Landscape: Vincent E. Gaillard

Lunch Break – Delegates Networking

14:30 - 15:30
Lunch Break – Delegates Networking

INDUSTRY PIPELINE (ΙΙ)

15:30-16:00

INDUSTRY PIPELINE (ΙΙ)
Chairs: Ioannis Gkiozos, Eleftheria Ntalakou

15:30-16:00 BMS: Designing the landscape of Lung Cancer: Constantin Makris

THE SMOKING STIGMA – SPONSORED SYMPOSIUM BY FAIRLIFE

16:00-16:30

THE SMOKING STIGMA – SPONSORED SYMPOSIUM BY FAIRLIFE
Chairs: Stamatina Demiri, Demosthenes Bouros

16:00-16:30 When the past haunts the management of a patient: Korina Pateli-Bell & Cynthia Mikkelsen

INVITED LECTURE

16:30-17:00

INVITED LECTURE
Chairs: Ioannis Boukovinas, Flora Zagouri

Understanding and overcoming therapeutic resistance in Small Cell Lung Cancer: Triparna Sen

NEUROENDOCRINE TUMORS OF THE LUNG

17:00-18:30

NEUROENDOCRINE TUMORS OF THE LUNG
Chairs: Haiying Cheng, Georgios Evangelou, Konstantinos - Marios Soultanis

17:00-17:30 Pathology & Molecular classification: Keith M. Kerr
17:30-18:00 Surgical considerations: Brendon Stiles
18:00-18:30 Molecular targets for therapy: Where do we go from here: Natasha Leighl

Coffee Break – Delegates Networking

18:30-19:00
Coffee Break – Delegates Networking

State of the Art CLINICAL MANAGEMENT

19:00-20:30
State of the Art CLINICAL MANAGEMENT
Chairs: Filippos Koinis, Anastasios Boutis, Stefania Kokkali

19:00-19:30 SCLC: Salvage therapy: Haiying Cheng
19:30-20:00 Oncogenic fusions: Targeting ROS1, RET and NTRK: Fabrice Barlesi
20:00-20:30 NSCLC: Disease Progression after adjuvant IO: Natasha Leighl

OPENING CEREMONY

20:30-21:00
OPENING CEREMONY
Chairs: Kostas Syrigos, Aristotelis Bamias

20:30-21:00 Precision Medicine in Oncology: Edward Chu

Cocktail Reception – Delegates Networking

21:00-23:00
Cocktail Reception – Delegates Networking

LUNG CANCER IN THE ERA OF COVID19

09:00 - 10:30

LUNG CANCER IN THE ERA OF COVID19
Chairs: Evangelos Giamarellos-Bourboulis, Sotiris Moraitis, Petros Bakakos

09:00-09:20 LC screening challenges: Ioannis Gkiozos
09:20-09:40 Safety of LC surgery during the COVID19 pandemic: Levon Toufektzian
09:40-10:00 Optimizing LC management in the pandemic era: Iris Vlachantoni
10:00-10:20 Vaccination Guidelines for LC patients: Garyfallia Poulakou
10:20-10:30 Q&A

ΜESOTHELIOMA UPDATE

10:30 - 11:30

ΜESOTHELIOMA UPDATE
Chairs: Konstantinos Potaris, Kosmas Iliadis, Vasileios Skouras

10:30-10:50 WHO classification update of MPM: Ioannis Vamvakaris
10:50-11:10 Molecular targets for MPM: Future considerations: Marousa Kouvela
11:10-11:30 Radical surgery in MPM; is it possible?: Emmanuel Kefaloyannis

Coffee Break – Delegates Networking

11:30 - 12:00
Coffee Break – Delegates Networking

DEVELOPMENTAL CANCER THERAPEUTICS

12:30 - 14:00

DEVELOPMENTAL CANCER THERAPEUTICS
Chairs: Marios Bakogeorgos, Sofia Baka, Konstantinos Samitas

12:30-12:50 The changing landscape of Clinical Trials: Lamprini Stournara
12:50-13:10 Real World Data & drug development: Eleni Kokkotou
13:10-13:30 Big Data & A.I. in drug development: Dimitrios Fotiadis
13:30-14:00 Detection of lung cancer using absent sequences in cfDNA and cfRNA: Ilias Georgakopoulos-Soares

Lunch Break – Delegates Networking

14.30-15:30
14.30-15:30 Lunch Break – Delegates Networking

RADIOTHERAPY ISSUES IN THORACIC ONCOLOGY

17:00-18:30

RADIOTHERAPY ISSUES IN THORACIC ONCOLOGY
Chairs: Vasileios Kouloulias, Georgios Koukourakis, Zoi Kalaitzi

17:00-17:30 PCI: Time for reassessment? Suresh Senan
17:30-18:00 Combined use of Radiotherapy & TKIs: Ioannis Georgakopoulos
18:00-18:30 Combined use of Radiotherapy & Immunotherapy:George Maravelis

ΝAVIGATING THROUGH CONTRADICTORY RESULTS

09:00 - 11:00

ΝAVIGATING THROUGH CONTRADICTORY RESULTS
Chairs: Yesim Eralp, Helena Linardou, Vassilis Ramfidis

09:00-09:20 Aegean vs NADIM II: Giannis Mountzios
09:20-09:40 Impower010 vs. PEARLS: Mary O’ Brien
09:40-10:00 CheckMate 816 vs. IMpower 010: Antonio Passaro
10:00-10:20 Checkmate 816 vs PACIFIC: Mustafa Özguroglu
10:20-10.40 Keynote 189/407 vs Checkmate 9LA: Andriani Charpidou
10:40-11:00 Q&A

TREATING THE TISSUE

11:00 - 12:00

TREATING THE TISSUE
Chairs: Antonio Passaro, Nikolaos Touroutoglou, Sophia Tsagouli

11:00-11:15 NGS in clinical practice: do we really need it? How far are we?: Fred Hirsch
11:15-11:30 Applying liquid biopsy in the pathology service: Rajwanth Veluswamy
11:30-11:45 When we should/could rebiopsy: Keith M. Kerr
11:45-12:00 Maximizing the outcome from the pathology & molecular report: Jan von der Thusen

Coffee Break – Delegates Networking

12:00 - 12:30
Coffee Break – Delegates Networking

ΙNVITED LECTURE

12:30 - 13:00

ΙNVITED LECTURE
Chairs: Solange Peters, Andriani Charpidou, Konstantinos Stefanidis

12:30-13:00 Oligometastasis in Lung Cancer: Where is the ceiling?: Heather Wakelee

DEBATE: NEOADJUVANT vs. ADJUVANT THERAPY IN OPERABLE NSCLC

13:00 - 14:00

DEBATE: NEOADJUVANT vs. ADJUVANT THERAPY IN OPERABLE NSCLC
Chairs: Charles Rudin, Kostas Syrigos

13:00-13:30 For the neoadjuvant treatment: Solange Peters
13:30-14:00 For the adjuvant treatment: Heather Wakelee

State of the Art – SPONSORED SYMPOSIUM by MSD

14:00 - 14:30

State of the Art – SPONSORED SYMPOSIUM by MSD
Chairs: Sofia Agelaki, Kostas Syrigos

14:00-14:30 Setting the survival standards in mNSCLC: Antonio Passaro

State of the Art Lecture – Sponsored by ASTRAZENECA

14:30 - 15:00

State of the Art Lecture – Sponsored by ASTRAZENECA
Chairs: Christos Panopoulos, Christos Kosmas

14:30 – 15:00 Right Patient, Right Treatment at the Right Time: Jon Zugazagoitia, Jan von der Thusen

Lunch Break – Delegates Networking

15:00 - 16:00
Lunch Break – Delegates Networking

DESIGNING THE FUTURE – INDUSTRY PIPELINE (ΙΙΙ)

16:00 - 16:30

DESIGNING THE FUTURE – INDUSTRY PIPELINE (ΙΙΙ)
Chairs: Helen Gogas, Dimitris Dionysopoulos

Presenter: Zsofia Nagy-Erdei

PRACTICE CHANGING CONSIDERATIONS

16:30 - 18:00

PRACTICE CHANGING CONSIDERATIONS
Chairs: Pasi A. Jänne, Ilias Athanasiadis, Oraianthi Fiste

16:30-17:00 Immunotherapy in mNSCLC: when should we stop?: Heather Wakelee
17:00-17:30 How can we identify the minimal residual disease?: Charles Rudin
17:30-18:00 Can we convert unresectable NSCLC disease to resectable?: Witold Rzyman

Coffee Break – Delegates Networking

18:00-18:30
Coffee Break – Delegates Networking

OPTIMAL USE OF TKIs

18:30-20:10

OPTIMAL USE OF TKIs
Chairs: Sarah Goldberg, Maria Theochari, Dimitrios Dionysopoulos

18:30-18:50 Peri-operative TKI in EGFR mutant tumors and beyond: Jon Zugazagoitia
18:50-19:10 Uncommon EGFR mutations: Rajwanth Veluswamy
19:10-19:30 How targetable is KRAS?: Kostas Syrigos
19:30-19:50 Targeting c-Met: Pasi A. Jänne
19:50-20:10 Whole Transcriptome Sequencing in therapeutic Decision making: Haiying Cheng

DESIGNING THE FUTURE OF LUNG CANCER TREATMENT

20:10-21:10

DESIGNING THE FUTURE OF LUNG CANCER TREATMENT
Chairs: Fred Hirsch, Athanasios Kotsakis, Ioannis Boukovinas

20:10-20:25 Latest advances in immunotherapy biomarkers for NSCLC: Kurt A. Schalper
20:25-20:40 SCLC: After Immunotherapy what?: Charles Rudin
20:40-20:55 Overcoming IO resistance: Sarah Goldberg
20:55-21:10 Overcoming EGFR resistance: Pasi A. Jänne

State of the Art CLINICAL MANAGEMENT

09:00 - 10:30

State of the Art CLINICAL MANAGEMENT
Chairs: George Sotiropoulos, Kalliopi Athanassiadi, Panagiotis Pandelakos

09:00-09:20 Segmectomy or Lobectomy? Brendon Stiles
09:20-09:40 Optimal Management of Brain Mets: Sarah Goldberg
09:40-10:00 Adrenal Solitary Lesion: Ernestos Beroukas
10:00-10:20 Systemic Treatment of oligometastatic disease: Yesim Eralp
10:20-10:30 Q&A

INEQUALITIES IN LUNG CANCER MANAGEMENT: THE ATHENS DECLARATION

09:00 - 10:30

INEQUALITIES IN LUNG CANCER MANAGEMENT: THE ATHENS DECLARATION
Chairs: Kostas Syrigos, Roy S. Herbst, Fred Hirsch

09:00-09:10 Ethnic & gender discriminations in Lung Cancer diagnosis & Management: Heather Wakelee
09:00-09:10 Gender discrepancies: Sofia Agelaki
09:20-09:30 The North America picture: Roy S. Herbst
09:30-09:40 The Developing countries picture: Ola Khorshid
09:40-09:50 Mind the Gap: Kostas Syrigos / Mary E. Bussell
09:50-10:30 Open Discussion by all participants

PERSONALIZED MEDICINE: SO CLOSE AND YET SO FAR

10:30 - 11:30

PERSONALIZED MEDICINE: SO CLOSE AND YET SO FAR
Chairs: Dimitris Mavroudis, Meletios Athanasios Dimopoulos

10:30-11:00 The Go To Action report from New York meeting: Fred Hirsch
11:00-11:30 Twenty Years of Progress in the Treatment of NSCLC:
What Does the Future Hold: Roy S. Herbst

Under the auspices of National &
Kapodistrian University of Athens 1. 14th ICCE Global Coach Conference 2023 Website : https://www.gcc2023-sg.com | 2. EPHyC 2024 Website : https://www.ephyc2024.com/ | 3. Congreso Aquitania Website : https://www.congresoaquitania.com | 4. Isolated Biomolecules and Biomolecular Interactions 2024 Website : https://ibbi2024.com |5. India Breast Meeting Website : https://www.indiabreastmeeting2024.com | 6. Aiclf 2024 Website : https://www.aiclf2024.net | 7. V CONGRESO PANAMERICANO DE ENFERMEDAD DE CROHN Y COLITIS ULCEROSA Website : https://panccogadeccu2024.com | 8. Congreso Nacional de Alimentos de la Agricultura Familiar y la Economía Social Website : https://www.congresodealimentos.com | 9. Interbancario 2024 Website : https://interbancario2024.com | 10. Geological Society of Thailand 2024 Website : https://geosea2024.com/ | 11. 2º Congreso Europeo Pacientes Mácula Retina Website : https://www.congresoeuropeomacularetina.com | 12. Core Energetics Conv 2024 Website : https://www.coreconvention2024.com | 13. I Congreso Colombiano de Senderismo y Montaña Website : https://www.congresocolombianosenderismo.com | 14. Athletes for Peace and Freedom International Sports Conference Website : https://afpf-conference.com | 15. International Carp Conference 2023 Website : https://carpconferencehungary.com |16. I Congreso y Muestra Mundo Senior Website : https://congresoseniorcordoba.com | 17. ENS Conference Website : https://ens-conference-tunis.com | 18. International Lung Cancer Network - 23-25 June 2023 Website : https://www.ilcnconference.com | 19. III Congreso de Familia Website : https://www.congresoinfanciafamiliaycapacidad.com | 20. SDG Conference Portugal Website : https://sdgconferenceportugal.com | 21. Digital Economy Regional Conference Website : https://digitalregionalconference.org | 22. Surveys2Discoveries Website : https://www.s2dconference.com | 23. Partnership conferenece 2023 Website : https://partnershipconference2023.com | 24. LAMA2 Muscular Dystrophy Conference 2023 Website : https://www.lama2-mdconference2023.com | 25. COR CONFERENCE Website : https://www.corconference.com | 26. RCAA Conference 2023 Website : https://www.rcaaconference2023.com | 27. kaynak kongresi Website : https://www.kaynakkongresi.org | 28. The 4th International 7th National Intercultural Nursing Congress Website : https://kulturlerarasihemsirelikkongresi.org | 29. IPBA - Indonesia Website : https://ipba2023regconf.com | 30. Ximus Pres Conference Website : https://www.ximuspresconference.com | 31. Joint International Congress Website : https://www.jointinternationalcongress.com | 32. XV Congreso Quemados Website : https://xvcongresoquemados.com | 33. Faith, Spirituality and Social Change Conference Series Website : https://www.fsscconference.org.uk | 34. UKPHA - 17th Annual Public Health Forum Website : https://www.ukphaconference.org.uk | 35. SMART CONFERENCES Website : https://www.smartconferences.org.uk | 36. The Congregational Website : https://www.thecongregational.org.uk | 37. Congreso Voluntariado Canarias Website : https://congresovoluntariadocanarias.org |38. سومین کنفرانس بین المللی فناوری های نوین در علوم Website : https://mtsconf.com | 39. TERIAS Conference Website : https://www.iasconference.org | 40. The Higher Education Climate Dialogues Website : https://hecdconference.org | 41. Konferencija Mladih Preduzetnika Website : https://konferencijamladihpreduzetnika.com | 42. Kenevir Konferansı Website : https://www.kenevirkonferansi.com | 43. İntegratif ve Anadolu Tıbbı Kongresi Website : https://integratifveanadolutibbikongresi.org | 44. 1st International Congress 10th National Congress Website : https://www.rstbilimkongresi.com | 45. TED x University of Bucharest Website : https://tedxuniversityofbucharest.com | 46. Ulusal Neonatoloji Kongresi Website : https://uneko2023.org | 47. TheoBio2023 Website : https://theobio2023.com | 48. Fcs 2023 Website : https://www.fcs2023.com | 49. MDIT X DD 2023 Website : https://www.mdit2023.com | 50. UHAC2023 Website : https://uhac2023.com